SCHEMBL5225577

SCHEMBL5225577

Cn1cncc1C(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)c(N)c1nccn12

nearest known ligand 0.58

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FNTA P49354 12/20 0.58
FNTB P49356 12/20 0.58
IDO1 P14902 1/20 0.38
PGGT1B P53609 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5221738 0.83 FNTA (0.58) FNTAFNTBIDO1PGGT1B
SCHEMBL7643836 0.81 FNTA (0.47) FNTAFNTBIDO1PGGT1B
SCHEMBL7645793 0.79 FNTA (0.47) FNTAFNTBIDO1PGGT1B
SCHEMBL13186537 0.73 FNTA (1.00) FNTAFNTB
SCHEMBL5514757 0.73 FNTA (0.80) FNTAFNTBIDO1PGGT1B
SCHEMBL5733786 0.73 FNTA (1.00) FNTAFNTB
SCHEMBL7217940 0.73 FNTA (0.39) FNTAFNTBIDO1
SCHEMBL1198369 0.72 FNTA (0.62) FNTAFNTBIDO1PGGT1B
SCHEMBL168438 0.72 FNTA (0.62) FNTAFNTBIDO1PGGT1B
SCHEMBL5778239 0.71 FNTA (0.68) FNTAFNTBIDO1PGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1815247-A2 THERAPEUTIC USE OF FARNESYLTRANSFERASE INHIBITORS AND METHODS OF MONITORING THE EFFICACY THEREOF JANSSEN PHARMACEUTICA N.V. (BE) 2007-08-08 EP disclosed
WO-2006052718-A2 FARNESYLTRANSFERASE INHIBITORS FOR TREATING SEPSIS JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-18 WO disclosed